Consumer Cyclical
Live Price
Offline$0.445
-3.05% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Companhia Brasileira de Distribuição (CBD) is a Consumer Cyclical stock with a market cap of $218.06M. The stock last traded around $0.45. Baseline metrics include revenue growth of -2.4%, EPS growth of +55.5%, a dividend yield of 0.0%. What stands out right now is revenue -2.4%, EPS +55.5%, free cash flow +224.2% with operating margin 0.9% and ROIC -1.0%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CBD price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CBD
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CBD Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CBD and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$51.3B
+214.5% YoY
FY Net Income
$1.1B
+36500.0% YoY
Free Cash Flow
$2.3B
+54.1% YoY
Revenue Growth
-2.4%
EPS Growth
+55.5%
Gross Margin
39.7%
Net Margin
7.7%
Income statement
BRL
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 18.8B | 19.3B | 17.3B | 16.3B | 51.3B |
| Gross Profit | 5.2B | 4.8B | 4.3B | 4.4B | 13.7B |
| Operating Income | -436M | 97M | -68M | 317M | 2.2B |
| EBITDA | 373M | 2.2B | 1.8B | 2.4B | 5.6B |
| Net Income | -2.4B | -2.3B | -1.0B | -3M | 1.1B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
BRL
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.6B | 3.0B | 3.8B | 8.3B | 8.7B |
| Total Assets | 19.7B | 24.2B | 43.8B | 49.4B | 53.3B |
| Total Liabilities | 16.8B | 19.5B | 30.1B | 33.1B | 36.5B |
| Shareholder Equity | 2.9B | 4.7B | 11.5B | 13.6B | 13.7B |
| Total Debt | 8.5B | 9.6B | 9.9B | 15.2B | 17.5B |
| Net Debt | 5.9B | 6.6B | 6.1B | 6.9B | 8.8B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
4.7B
+73.8% YoY
Capital Expenditures
2.5B
-96.5% YoY
Free Cash Flow
2.3B
+54.1% YoY
Key ratios
Gross Margin
39.7%
Operating Margin
0.9%
Net Margin
7.7%
ROE
-48.1%
Debt / Equity
3.06x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.